English
Special Design for Camptothecin II - Irinotecan Hydrochloride CAS 100286-90-6 API USP Standard High Purity – Ruifu Featured Image
  • Special Design for Camptothecin II - Irinotecan Hydrochloride CAS 100286-90-6 API USP Standard High Purity – Ruifu

Special Design for Camptothecin II - Irinotecan Hydrochloride CAS 100286-90-6 API USP Standard High Purity – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

We enjoy a very good reputation among our customers for our excellent product quality, competitive price and the best service for Molecular Formula C10H12N2O2, (R)-(-)-3-Pyrrolidinol Hydrochloride, p-Anisic Acid, Our goal is "blazing new ground, Passing Value", in the potential, we sincerely invite you to mature up with us and create a vivid foreseeable future jointly!
Special Design for Camptothecin II - Irinotecan Hydrochloride CAS 100286-90-6 API USP Standard High Purity – Ruifu Detail:

Manufacturer with High Purity and Competitive Price
Supply Irinotecan and Related Intermediates:
Irinotecan Hydrochloride CAS: 100286-90-6
Irinotecan Free Base CAS: 97682-44-5
Irinotecan Hydrochloride Trihydrate CAS: 136572-09-3
7-Ethyl-10-Hydroxycamptothecin CAS: 86639-52-3
1-Chlorocarbonyl-4-Piperidinopiperidine Hydrochloride CAS: 143254-82-4

Chemical Name Irinotecan Hydrochloride
Synonyms Camptothecin II; CPT-II
CAS Number 100286-90-6
CAT Number RF-API50
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C33H39ClN4O6
Molecular Weight 623.15
Melting Point 250-256℃ (dec.)
Storage Conditions Under Ambient Temperature
Brand Ruifu Chemical
Item Specifications
Appearance White or Off-White Powder
Solubility Soluble in water and methanol, slightly soluble in chloroform, ethanol
Identification IR The infrared absorption spectrum of the test sample should consistent with  that of the reference standard
Identification HPLC The retention time of major peak of the sample solution should correspond to that of the reference standard.
Identification Meets the requirements of the tests for Chloride Positive reaction 
Moisture (K.F) 7.0%~9.0% w/w
Residue on Ignition ≤0.10% 
Heavy Metals ≤20ppm
Irinotecan Hydrochloride Enantiomer ≤0.10% (HPLC)
7-Desethyl Irinotecan ≤0.15% 
Irinotecan Related Compound A ≤0.15% 
11-Ethyl Irinotecan ≤0.15% 
Camptothecin ≤0.15% 
Irinotecan Related Compound B ≤0.15% 
7-Ethylcanptothecin ≤0.15% 
7,11-Diethyl-10-Hydroxy Camptothecin ≤0.15% 
Any Unspecified Impurity ≤0.10% 
Total Impurities ≤0.50% 
Residual Solvents (GC)
Methanol ≤2000ppm
Acetone ≤2000ppm
Dichloromethane ≤500ppm
Peteoleum Ether: ≤100ppm
Ethyl Acetate ≤2000ppm
Benzene ≤2ppm
Bacterial Endotoxins ≤0.29 EU/mg Irinotecan
Microbial Limits Total Aerobic Microbial Count: <1000 cfu/g
Molds and Yeasts  <100 cfu/g
Purity / Analysis Method ≥99.0% (HPLC, on the anhydrous basis)
Test Standard United States Pharmacopeia (USP) Standard
Usage Active Pharmaceutical Ingredient (API)

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

1

lrinotecan hydrochloride (CAS 100286-90-6), a semi-synthetic, water soluble derivative of the potent anticancer agent camptothecin, was launched in Japan for the treatment of lung, ovarian, and cervical cancers. lrinotecan exerts its antitumor activity via inhibition of topoisomerase I, a cellular enzyme that is involved in maintaining the topographic structure of DNA during the process of translation, transcription, and mitosis. lrinotecan undergoes de-esterification in vivo to yield an active metabolite, SN-38, which is 1000-fold more potent than the parent. Although being much less toxic than camptothecin, a significant number of patients in clinical trials exhibited side effects of leukopenia, diarrhea, nauseahromiting, and alopecia. Combination therapy of irinotecan with another widely used anticancer agent, cisplatin, has been reported to be superior to either agent alone. lrinotecan is in clinical trials for gastrointestinal, breast, skin, colorectal, pancreatic cancers, mesothelioma and non-Hodgkin’s lymphoma.

Product detail pictures:

Special Design for Camptothecin II - Irinotecan Hydrochloride CAS 100286-90-6 API USP Standard High Purity – Ruifu detail pictures

Related Product Guide:
We also offer you product sourcing and flight consolidation expert services. We've our personal manufacturing unit and sourcing business. We can offer you virtually every variety of merchandise associated to our item range for Special Design for Camptothecin II - Irinotecan Hydrochloride CAS 100286-90-6 API USP Standard High Purity – Ruifu , The product will supply to all over the world, such as: Turkey, Singapore, California, All our staffs believe that: Quality builds today and service creates future. We know that good quality and the best service are the only way for us to achieve our customers and to achieve ourselves too. We welcome customers all over the word to contact us for future business relationships. Our products are the best. Once Selected, Perfect Forever!
    • This is a honest and trustworthy company, technology and equipment are very advanced and the prodduct is very adequate, there is no worry in the suppliment.
    5 Stars By Jean from The Swiss - 2018.08.12 12:27
    The factory can meet continuously developing economic and market needs, so that their products are widely recognized and trusted, and that's why we chose this company.
    5 Stars By Giselle from Italy - 2017.12.31 14:53
    Write your message here and send it to us